Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution

(2018) A. Hunter Shain et al.   CANCER CELL

Genetic alterations in main candidate genes during melanoma progression

(2018) Maria Cristina Sini et al.   Oncotarget

Melanoma

(2018) Dirk Schadendorf et al.   LANCET

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

(2018) Giuseppe Palmieri et al.   Current Oncology Reports

Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas

(2018) Fengju Chen et al.   MOLECULAR CANCER RESEARCH

Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy

(2017) Antonio Cossu et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Somatic mutation analysis in melanoma using targeted next generation sequencing

(2017) Allen P. Miraflor et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases

(2017) Enda J. Hannan et al.   MEDICINE

Whole-genome landscapes of major melanoma subtypes

(2017) Nicholas K. Hayward et al.   NATURE

Intratumor and Intertumor Heterogeneity in Melanoma

(2017) Tomasz M. Grzywa et al.   Translational Oncology

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

(2017) Blanca de Unamuno Bustos et al.   Scientific Reports

Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma

(2016) Milena Casula et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genomic Classification of Cutaneous Melanoma

(2015) Rehan Akbani et al.   CELL

Intra- and Inter-Tumoral Homogeneity of BRAF V600E Mutations in Melanoma Tumors

(2015) Erica Riveiro-Falkenbach et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Beyond BRAF V600 : Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma

(2015) Alan E. Siroy et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

(2015) Helena Cirenajwis et al.   Oncotarget

Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets

(2015) Giuseppe Palmieri et al.   Frontiers in Oncology

Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site

(2014) Aleksandra Gos et al.   ANNALS OF SURGICAL ONCOLOGY

Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: Implications on optimized targeted therapy

(2014) Maya Saroufim et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

A Landscape of Driver Mutations in Melanoma

(2012) Eran Hodis et al.   CELL

BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma

(2012) Maria Colombino et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

(2012) Grazia Palomba et al.   Journal of Translational Medicine

Melanoma genome sequencing reveals frequent PREX2 mutations

(2012) Michael F. Berger et al.   NATURE

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

(2012) Michael Krauthammer et al.   NATURE GENETICS

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression

(2011) J Lin et al.   BRITISH JOURNAL OF CANCER

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

(2009) Milena Casula et al.   BMC CANCER